Susquehanna Fundamental Investments LLC Invests $19.09 Million in The Clorox Company (NYSE:CLX)

Susquehanna Fundamental Investments LLC bought a new position in The Clorox Company (NYSE:CLX - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The fund bought 117,536 shares of the company's stock, valued at approximately $19,089,000. Susquehanna Fundamental Investments LLC owned 0.09% of Clorox as of its most recent filing with the SEC.

Other large investors have also recently modified their holdings of the company. Vanguard Group Inc. increased its position in Clorox by 0.8% during the fourth quarter. Vanguard Group Inc. now owns 15,507,152 shares of the company's stock valued at $2,518,517,000 after acquiring an additional 124,428 shares during the last quarter. Geode Capital Management LLC boosted its stake in shares of Clorox by 2.3% during the 4th quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company's stock worth $501,925,000 after purchasing an additional 69,969 shares during the period. Stifel Financial Corp grew its holdings in Clorox by 0.4% during the 4th quarter. Stifel Financial Corp now owns 2,344,408 shares of the company's stock valued at $380,761,000 after purchasing an additional 9,582 shares during the last quarter. Norges Bank purchased a new stake in Clorox in the 4th quarter worth about $259,041,000. Finally, FMR LLC lifted its stake in Clorox by 75.4% in the fourth quarter. FMR LLC now owns 1,361,758 shares of the company's stock worth $221,163,000 after purchasing an additional 585,526 shares during the last quarter. Institutional investors own 78.53% of the company's stock.

Clorox Stock Up 1.8 %

CLX stock traded up $2.44 during trading on Tuesday, hitting $141.22. 2,008,105 shares of the company's stock traded hands, compared to its average volume of 1,303,889. The firm has a market capitalization of $17.40 billion, a P/E ratio of 38.58, a PEG ratio of 2.62 and a beta of 0.61. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The business has a fifty day simple moving average of $145.37 and a two-hundred day simple moving average of $155.48.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings results on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the firm posted $2.16 EPS. Sell-side analysts anticipate that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 3.46%. The ex-dividend date is Wednesday, April 23rd. Clorox's payout ratio is 133.33%.

Analyst Upgrades and Downgrades

CLX has been the topic of several recent analyst reports. Wells Fargo & Company reduced their price target on Clorox from $155.00 to $145.00 and set an "equal weight" rating on the stock in a report on Wednesday, April 16th. Royal Bank of Canada reiterated a "sector perform" rating and issued a $150.00 target price on shares of Clorox in a research note on Thursday, January 30th. StockNews.com lowered shares of Clorox from a "buy" rating to a "hold" rating in a research note on Sunday, January 5th. Barclays reduced their price target on shares of Clorox from $139.00 to $134.00 and set an "underweight" rating on the stock in a research note on Friday, April 11th. Finally, JPMorgan Chase & Co. dropped their target price on shares of Clorox from $173.00 to $151.00 and set a "neutral" rating on the stock in a research note on Friday, April 11th. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average target price of $153.83.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.